FDA chooses 5 for $500M data analytics pact
Gettyimages.com / Yuichiro Chino
By
Ross Wilkers
These awards take place two years after the Food and Drug Administration unveiled a modernization plan focused on centering everything it does around data.
Five companies have won positions on a potential five-year, $500 million blanket purchase agreement for data and analytics support services to the Food and Drug Administration.
Agency officials made their selections on Monday and received 23 bids in total for the pact, according to Federal Procurement Data System records.
Winners are as follows:
- Accenture’s U.S. federal subsidiary
- Booz Allen Hamilton
- Deloitte Consulting
- Next Phase Solutions and Services
- Trillion ERP VentureTech
These awards take place two years after the FDA unveiled its Enterprise Modernization Action Plan, which spells out how the agency is looking to use data as a foundation in everything it does.
The FDA used the General Services Administration’s Multiple Award Schedules program to award this BPA, which runs through to August 2029.